ME US90138Q1085

Report

Delayed Nasdaq - 05/16 04:00:01 pm EDT
2.780	USD		-1.77%

05/12	23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results	GL
05/12	23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results	AQ
04/13	23ANDME : Current Report (Form 8-K)	PU

Calendar

Event chart 23ANDME HOLDING CO.

Upcoming events on 23ANDME HOLDING CO.

08/12/22		Q1 2023 Earnings Release (Projected)
11/09/22		Interim 2023 Earnings Release (Projected)
08/11/23		Q1 2024 Earnings Release (Projected)
11/08/23		Interim 2024 Earnings Release (Projected)

Past events on 23ANDME HOLDING CO.

04/10/22 \| 02:30pm		American association of cancer research meeting - abstract number: 602 / 12
04/10/22 \| 02:30pm		American association of cancer research meeting - abstract number: 603 / 13
03/07/22 \| 02:50pm		Cowen & Co. Health Care Conference
02/24/22 \| 01:15pm		Citi Research Healthcare Conference
02/10/22 \| 04:30pm		Q3 2022 Earnings Call
02/10/22 \| 04:04pm		Q3 2022 Earnings Release
01/18/22 \| 11:00am		R&D Day
12/02/21 \| 02:15pm		Evercore ISI HealthCONx Conference
11/22/21		Piper Sandler Virtual Healthcare Conference
11/11/21 \| 12:10pm		Credit Suisse Healthcare Conference

Past dividends on 23ANDME HOLDING CO.

- No events available -

Annual results

Fiscal Period : March		2021	2022
Sales M $	Released Forecast Spread		275
Operating income (EBITDA) M $	Released Forecast Spread		-207
Operating profit (EBIT) M $	Released Forecast Spread		-231
Pre-Tax Profit (EBT) M $	Released Forecast Spread		-250
Net income M $	Released Forecast Spread	-184	-250
EPS $	Released Forecast Spread	-4,23	-0,70
Announcement Date		06/21/2021	-

Quarterly results

Fiscal Period : March

2022 Q2

2022 Q3

2022 Q4

Sales
M $

Released
Forecast
Spread

55,2
55,7
-0,91%

56,9
54,3
4,8%

103

Operating profit
(EBIT)
M $

Released
Forecast
Spread

-46,4
-49,6
6,3%

-96,7
-59,7
-62%

-69,1

EPS
$

Released
Forecast
Spread

-0,04
-0,11
64%

-0,21
-0,15
-40%

-0,15

Announcement Date

11/10/2021

02/10/2022

Previous year

Next Year

Upcoming sector events for 23ANDME HOLDING CO.

05/20/22		DR. LAL PATHLABS LIMITED : FY 2022 Earnings Release (Projected)
08/10/22		DR. LAL PATHLABS LIMITED : Q1 2023 Earnings Release (Projected)
08/11/22		SYNLAB AG : Interim 2022 Earnings Release
08/12/22		GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. : Interim 2022 Earnings Release (Projected)
08/24/22		SONIC HEALTHCARE LIMITED : FY 2022 Earnings Release
10/28/22		GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. : Q3 2022 Earnings Release (Projected)
11/10/22		SYNLAB AG : Q3 2022 Earnings Release
11/11/22		DR. LAL PATHLABS LIMITED : Interim 2023 Earnings Release (Projected)
02/09/23		DR. LAL PATHLABS LIMITED : Q3 2023 Earnings Release (Projected)
02/15/23		SONIC HEALTHCARE LIMITED : Interim 2023 Earnings Release (Projected)

More events

Past sector events for 23ANDME HOLDING CO.

05/12/22		SYNLAB AG : Q1 2022 Earnings Release
04/27/22		GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. : Q1 2022 Earnings Release
04/27/22		GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. : FY 2021 Earnings Release
03/16/22		SYNLAB AG : FY 2021 Earnings Release
02/20/22 \| 02:54pm		SONIC HEALTHCARE LIMITED : Interim 2022 Earnings Release
02/10/22 \| 04:23am		DR. LAL PATHLABS LIMITED : Q3 2022 Earnings Release
11/10/21		SYNLAB AG : Q3 2021 Earnings Release
10/26/21 \| 07:21am		DR. LAL PATHLABS LIMITED : Interim 2022 Earnings Release
10/26/21		GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. : Q3 2021 Earnings Release
08/22/21 \| 06:39pm		SONIC HEALTHCARE LIMITED : FY 2021 Earnings Release

More events

Analysis

23andMe : to buy telehealth firm Lemonaid for $400 mln